180 related articles for article (PubMed ID: 30573779)
1. Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.
Cross NCP; Hoade Y; Tapper WJ; Carreno-Tarragona G; Fanelli T; Jawhar M; Naumann N; Pieniak I; Lübke J; Ali S; Bhuller K; Burgstaller S; Cargo C; Cavenagh J; Duncombe AS; Das-Gupta E; Evans P; Forsyth P; George P; Grimley C; Jack F; Munro L; Mehra V; Patel K; Rismani A; Sciuccati G; Thomas-Dewing R; Thornton P; Virchis A; Watt S; Wallis L; Whiteway A; Zegocki K; Bain BJ; Reiter A; Chase A
Leukemia; 2019 Feb; 33(2):415-425. PubMed ID: 30573779
[TBL] [Abstract][Full Text] [Related]
2.
Yin CC; Tam W; Walker SM; Kaur A; Ouseph MM; Xie W; K Weinberg O; Li P; Zuo Z; Routbort MJ; Chen S; Medeiros LJ; George TI; Orazi A; Arber DA; Bagg A; Hasserjian RP; Wang SA
Haematologica; 2024 Jun; 109(6):1825-1835. PubMed ID: 37981812
[TBL] [Abstract][Full Text] [Related]
3. A case of hypereosinophilic syndrome with STAT5b N642H mutation.
Ding F; Wu C; Li Y; Mukherjee S; Ghosh S; Arrossi AV; Krishnan S
Oxf Med Case Reports; 2021 Jan; 2021(1):omaa129. PubMed ID: 33542831
[TBL] [Abstract][Full Text] [Related]
4. Chronic eosinophilic leukemia with recurrent STAT5B N642H mutation-An entity with features of myelodysplastic syndrome/ myeloproliferative neoplasm overlap.
Sreedharanunni S; Jamwal M; Balakrishnan A; Aravindan AV; Sharma R; Singh N; Rajpal S; Singla S; Khadwal AR; Ahluwalia J; Malhotra P; Das R
Leuk Res; 2022 Jan; 112():106753. PubMed ID: 34856508
[No Abstract] [Full Text] [Related]
5. Structural and functional consequences of the STAT5B
de Araujo ED; Erdogan F; Neubauer HA; Meneksedag-Erol D; Manaswiyoungkul P; Eram MS; Seo HS; Qadree AK; Israelian J; Orlova A; Suske T; Pham HTT; Boersma A; Tangermann S; Kenner L; Rülicke T; Dong A; Ravichandran M; Brown PJ; Audette GF; Rauscher S; Dhe-Paganon S; Moriggl R; Gunning PT
Nat Commun; 2019 Jun; 10(1):2517. PubMed ID: 31175292
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.
Groh M; Fenwarth L; Labro M; Boudry A; Fournier E; Wemeau M; Marceau-Renaut A; Daltro de Oliveira R; Abraham J; Barry M; Blanche P; Bodard Q; Braun T; Chebrek S; Decamp M; Durel CA; Forcade E; Gerfaud-Valentin M; Golfier C; Gourguechon C; Grardel N; Kosmider O; Martis N; Melboucy Belkhir S; Merabet F; Michon A; Moreau S; Morice C; Néel A; Nicolini FE; Pascal L; Pasquier F; Pieragostini A; Roche-Lestienne C; Rousselot P; Terriou L; Thiebaut-Bertrand A; Viallard JF; Preudhomme C; Kahn JE; Lefevre G; Duployez N;
Am J Hematol; 2024 Jun; 99(6):1108-1118. PubMed ID: 38563187
[TBL] [Abstract][Full Text] [Related]
7. The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse.
Bandapalli OR; Schuessele S; Kunz JB; Rausch T; Stütz AM; Tal N; Geron I; Gershman N; Izraeli S; Eilers J; Vaezipour N; Kirschner-Schwabe R; Hof J; von Stackelberg A; Schrappe M; Stanulla M; Zimmermann M; Koehler R; Avigad S; Handgretinger R; Frismantas V; Bourquin JP; Bornhauser B; Korbel JO; Muckenthaler MU; Kulozik AE
Haematologica; 2014 Oct; 99(10):e188-92. PubMed ID: 24972766
[No Abstract] [Full Text] [Related]
8. Unveiling myeloid transformation: T-LGLL with eosinophilia masking myeloid-associated STAT5B mutation culminating in AML.
Dong Q; Wang Y; Xiu Y; Wu X; O'Neill S; Meyerson H; Suske T; Moriggl R; Hu S; Wang W; Zhao C
Br J Haematol; 2024 Jun; 204(6):2487-2491. PubMed ID: 38508872
[No Abstract] [Full Text] [Related]
9. Myeloid neoplasms with eosinophilia.
Reiter A; Gotlib J
Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
[TBL] [Abstract][Full Text] [Related]
10. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.
Rajala HL; Eldfors S; Kuusanmäki H; van Adrichem AJ; Olson T; Lagström S; Andersson EI; Jerez A; Clemente MJ; Yan Y; Zhang D; Awwad A; Ellonen P; Kallioniemi O; Wennerberg K; Porkka K; Maciejewski JP; Loughran TP; Heckman C; Mustjoki S
Blood; 2013 May; 121(22):4541-50. PubMed ID: 23596048
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.
Kelemen K; Saft L; Craig FE; Orazi A; Nakashima M; Wertheim GB; George TI; Horny HP; King RL; Quintanilla-Martinez L; Wang SA; Rimsza LM; Reichard KK
Am J Clin Pathol; 2021 Feb; 155(2):179-210. PubMed ID: 33367563
[TBL] [Abstract][Full Text] [Related]
12. Primary eosinophilic disorders: a concise review.
Pardanani A; Tefferi A
Curr Hematol Malig Rep; 2008 Jan; 3(1):37-43. PubMed ID: 20425445
[TBL] [Abstract][Full Text] [Related]
13. Rare occurrence of a STAT5B N642H mutation in adult T-cell acute lymphoblastic leukemia.
Ma X; Wen L; Wu L; Wang Q; Yao H; Wang Q; Ma L; Chen S
Cancer Genet; 2015; 208(1-2):52-3. PubMed ID: 25749351
[No Abstract] [Full Text] [Related]
14. A Recurrent
Kieslinger M; Swoboda A; Kramer N; Freund P; Pratscher B; Neubauer HA; Steinborn R; Wolfesberger B; Fuchs-Baumgartinger A; Moriggl R; Burgener IA
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680385
[TBL] [Abstract][Full Text] [Related]
15. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
16. Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea.
Ma CA; Xi L; Cauff B; DeZure A; Freeman AF; Hambleton S; Kleiner G; Leahy TR; O'Sullivan M; Makiya M; O'Regan G; Pittaluga S; Niemela J; Stoddard J; Rosenzweig SD; Raffeld M; Klion AD; Milner JD
Blood; 2017 Feb; 129(5):650-653. PubMed ID: 27956386
[No Abstract] [Full Text] [Related]
17. Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia.
Bhattacharya D; Teramo A; Gasparini VR; Huuhtanen J; Kim D; Theodoropoulos J; Schiavoni G; Barilà G; Vicenzetto C; Calabretto G; Facco M; Kawakami T; Nakazawa H; Falini B; Tiacci E; Ishida F; Semenzato G; Kelkka T; Zambello R; Mustjoki S
Blood Cancer J; 2022 Feb; 12(2):31. PubMed ID: 35210405
[TBL] [Abstract][Full Text] [Related]
18. Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia.
Arefi M; Robledo C; Peñarrubia MJ; García de Coca A; Cordero M; Hernández-Rivas JM; García JL
Eur J Haematol; 2014 Nov; 93(5):422-8. PubMed ID: 24813417
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies.
Odinius TO; Buschhorn L; Wagner C; Hauch RT; Dill V; Dechant M; Buck MC; Shoumariyeh K; Moog P; Schwaab J; Reiter A; Brockow K; Götze K; Bassermann F; Höckendorf U; Branca C; Jost PJ; Jilg S
J Cancer Res Clin Oncol; 2022 Feb; 148(2):331-340. PubMed ID: 34654952
[TBL] [Abstract][Full Text] [Related]
20. Unusual infant eosinophilia: myeloid neoplasm with FGFR1 abnormality.
Li W; Cooley LD
Blood; 2016 Sep; 128(10):1440. PubMed ID: 27769039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
